Vitiligo treated successfully with arthritis drug and light therapy

January 31, 2018, Yale University

Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy—the medication and light—to restore skin color in patients.

The study, led by associate professor of dermatology Brett King, M.D., was published in JAMA Dermatology on January 31, 2018.

King and his colleagues reported two cases of patients with significant loss of skin color from vitiligo, a that destroys skin pigment, leaving white splotches where there had been color. For King's patients, standard treatments, such as steroid creams and light treatment, had failed to restore pigmentation. To address these difficult cases, the research team combined the medication, tofacitinib, with narrow band ultraviolet B light therapy. In recent experiments, King and Dr. John Harris, a dermatologist at University of Massachusetts-Worcester, had shown that tofacitinib keeps the immune system from attacking the skin cells that manufacture (color), and light stimulates pigment-making cells to restore color to the skin.

After a few months of the combination therapy, there was remarkable improvement, report the researchers: One patient saw near-total restoration of on her face, neck, chest, forearms, and shins. The other patient experienced similar success.

While more research is needed, the study highlights another advance by the Yale team in treating this and other stigmatizing skin conditions. "These findings will define treatment of vitiligo in the future," King said.

Explore further: For vitiligo patient, arthritis drug restores skin color

Related Stories

For vitiligo patient, arthritis drug restores skin color

June 24, 2015
A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that ...

MKTP surgery has long-term benefit for restoring skin pigmentation in vitiligo patients

July 27, 2017
A Henry Ford Hospital study has shown that skin transplant surgery has long-term benefit for restoring skin pigmentation caused by the skin disease vitiligo.

Researchers beat untreatable eczema with arthritis drug

July 20, 2015
Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia ...

Vitiligo treatment holds promise for restoring skin pigmentation

September 17, 2014
A treatment regimen is safe and effective for restoring skin pigmentation in vitiligo patients, according to a Henry Ford Hospital study.

Skin cell transplant may offer new hope to vitiligo patients

June 22, 2012
(HealthDay) -- Skin cell transplants can restore pigment to the skin of some patients with the disorder known as vitiligo, new research finds.

Skin transplant offers new hope for vitiligo patients

May 30, 2012
Henry Ford Hospital dermatologists say skin transplant surgery is safe and effective for restoring skin pigmentation caused by the skin disease vitligo.

Recommended for you

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

New evidence of a preventative therapy for gout

September 17, 2018
Among patients with cardiovascular disease, it's a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular ...

Paracetamol use in infancy is linked to increased risk of asthma in some teenagers

September 17, 2018
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at ...

Cord blood clue to respiratory diseases

September 15, 2018
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.